Adma Biologics Inc Ret. on assets
What is the Ret. on assets of Adma Biologics Inc?
The Ret. on assets of Adma Biologics Inc is 9.90%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on NASDAQ compared to Adma Biologics Inc
What does Adma Biologics Inc do?
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.
Companies with ret. on assets similar to Adma Biologics Inc
- CDK Global Inc has Ret. on assets of 9.89%
- Care Property Invest NV has Ret. on assets of 9.89%
- Tata Metaliks has Ret. on assets of 9.89%
- CGI Inc has Ret. on assets of 9.89%
- CGI has Ret. on assets of 9.89%
- Novotek AB has Ret. on assets of 9.90%
- Adma Biologics Inc has Ret. on assets of 9.90%
- Avis Budget has Ret. on assets of 9.90%
- Lisi () has Ret. on assets of 9.91%
- InterContinental Hotels PLC has Ret. on assets of 9.91%
- Intercontinental Hotels has Ret. on assets of 9.91%
- African Discovery has Ret. on assets of 9.91%
- Spark New Zealand has Ret. on assets of 9.91%